CPIX - Cumberland Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue40,741.76541,150.13133,025.5633,519.051
Cost of Revenue7,378.0957,370.5855,958.664,968.17
Gross Profit33,363.6733,779.54627,066.928,550.881
Operating Expenses
Research Development7,320.7973,901.3653,190.73,847.651
Selling General and Administrative30,664.17931,523.30723,115.29221,902.356
Non Recurring----
Others----
Total Operating Expenses48,132.53745,231.47934,458.69132,707.441
Operating Income or Loss-7,390.772-4,081.348-1,433.131811.61
Income from Continuing Operations
Total Other Income/Expenses Net368.636206.42298.269435.327
Earnings Before Interest and Taxes-7,390.772-4,081.348-1,433.131811.61
Interest Expense-195.848-92.904-106.392-73.856
Income Before Tax-7,022.136-3,874.926-1,334.8621,246.937
Income Tax Expense16.6364,174.889-330.924575.829
Minority Interest-274.266-198.562-127.38-68.125
Net Income From Continuing Ops-7,038.772-8,049.815-1,003.938671.108
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,963.068-7,978.633-944.683731.351
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,963.068-7,978.633-944.683731.351